Community Drug Board Inc is categorized under Specialty Outpatient Clinics, Nec in Akron, OH and active since 1974.
Community Drug Board Inc was established in 1974, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Specialty Outpatient Clinics, Nec business, which does work in the B2C market, and is classified as a Specialty Outpatient Clinics, Nec, under code number 6222100 by the NAICS.
If you are seeking more information, feel free to contact Theodore P Ziegler at the company’s single location by writing to 725 East Market St, Akron, Ohio OH 44305 or by phoning (330) 434-2400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Community Drug Board Inc |
| Contact Person: | Theodore P Ziegler |
| Address: | 725 East Market St, Akron, Ohio 44305 |
| Phone Number: | (330) 434-2400 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1974 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Specialty Outpatient Clinics, Nec |
| SIC Code: | 8093 |
| NAICS Code: | 6222100 |
| Share This Business: |
Community Drug Board Inc was started in 1974 to provide professional Specialty Outpatient Clinics, Nec under the SIC code 8093 and NAICS code 6222100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Theodore P Ziegler for inquiries that concern Community Drug Board Inc by calling the company number (330) 434-2400, as your correspondence is most welcome. Additionally, the physical location of the single location of Community Drug Board Inc can be found at the coordinates 41.07575,-81.49475 as well as the street address 725 East Market St in Akron, Ohio 44305.
For its online presence, you may visit Community Drug Board Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.